VenoStent

venostent.com

VenoStent is a clinical-stage therapeutic medical device company focused on improving vascular surgery outcomes through its innovative bioabsorbable wraps. Their flagship product, Self Wrap, is designed to enhance the usability and durability of arteriovenous access sites for chronic kidney disease patients requiring hemodialysis. With a significant market need, as evidenced by the high failure rates of dialysis access sites and the associated Medicare costs, VenoStent aims to address these challenges with its unique technology. The company is currently in the research and development phase and has received FDA breakthrough device designation, indicating strong potential for market impact and patient benefit.